BioCentury
ARTICLE | Clinical News

AAV2-hRPE65v2: Additional Phase III data

October 19, 2015 7:00 AM UTC

Additional data from an open-label, U.S. Phase III trial in 31 patients with inherited retinal dystrophies due to confirmed RPE65 gene mutations showed that SPK-RPE65 led to a mean improvement in func...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article